Specific inhibition of cytotoxicity of Shiga-like toxin 1 of enterohemorrhagic Escherichia coli by gallocatechin gallate and epigallocatechin gallate

Food Control

Volumn 42, Issue , 2014, Pages 263-269

  Miyamoto, Takahisa ^a   Toyofuku, Seiyo ^a   Tachiki, Narumi ^a   Kimura, Etsuko ^a   Zhou, Ting ^a   Ozawa, Tadahiro ^b   Nakayama, Motokazu ^b   Shigemune, Naofumi ^b   Shimatani, Kanami ^b   Tokuda, Hajime ^b   Honjoh, Ken ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KAO CORPORATION   (Japan)

Author keywords

Epigallocatechin gallate; Gallocatechin gallate; Inhibition; Siga like toxin 1

Indexed keywords

EID: 84897704726     PISSN: 09567135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodcont.2014.02.017     Document Type: Article

References (26)

1. Akiyoshi D.E., Sheoran A.S., Rich C.M., Richard L., Susan Chapman-Bonofiglio S., Tzipori S. Evaluation of Fab and F(ab')2 fragments and isotype variants of a recombinant human monoclonal antibody against Shiga toxin 2. Infection and Immunity 2010, 78:1376-1382.
2. Baxter N.J., Lilley T.H., Haslam E., Williamson M.P. Multiple interactions between polyphenols and a salivary proline-rich protein repeat result in complexation and precipitation. Biochemistry 1997, 36:5566-5577.
3. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., Karplus M. CHARMM: a program for macromolecular energy, minimizations and dynamics calculations. Journal of Computational Chemistry 1983, 4:187-217.
4. Charlton A.J., Baxter N.J., Khan M.L., Moir A.J., Haslam E., Davies A.P., et al. Polyphenol/peptide binding and precipitation. Journal of Agricultural and Food Chemistry 2002, 50:1593-1601.
5. Croxen M.A., Finlay B.B. Molecular mechanisms of Escherichia coli pathogenicity. Nature Reviews Microbiology 2010, 8:26-38.
6. Doughari J.H., Human I.S., Bennade S., Ndakidemi P.A. Phytochemicals as chemotherapeutic agents and antioxidants: possible solution to the control of antibiotic resistant verocytotoxin producing bacteria. Journal of Medicinal Plants Research 2009, 3(11):839-848.
7. Fraser M.E., Fujinaga M., Cherney M.M., Melton-Celsa A.R., Twiddy E.M., O'Brien A.D., et al. Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. Journal of Biological Chemistry 2004, 279:27511-27517.
8. Harmsen M.M., van Solt C.B., Hoogendoorn A., van Zijderveld F.G., Niewold T.A., van der Meulen J. Escherichia coli F4 fimbriae specific llama single-domain antibody fragments effectively inhibit bacterial adhesion invitro but poorly protect against diarrhoea. Veterinary Microbiology 2005, 111:89-98.
9. Heinnig-Pauka I., Stelljes I., Waldmann K.H. Studies on the effect of specific egg antibodies against Escherichia coli infections in piglets. Deutsche Tieraerztliche Wochenscherift 2003, 110:49-54.
10. Krautz-Peterson G., Chapman-Bonofiglio S., Boisvert K., Feng H., Herman I.M., Tzipori S., et al. Intracellular neutralization of Shiga toxin 2 by an A subunit-specific human monoclonal antibody. Infection and Immunity 2008, 76:1931-1939.
11. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
12. Li X., Wu P., Cheng S., Lv X. Synthesis and assessment of globotriose-chitosan conjugate, a novel inhibitor of Shiga toxins produced by Escherichia coli. Journal of Medicinal Chemistry 2012, 55(6):2702-2710.
13. Morinaga N., Iwamaru Y., Yahiro K., Tagashira M. Differential activities of plant polyphenols on the binding and internalization of cholera toxin in vero cells. Journal of Biological Chemistry 2005, 280:23303-23309.
14. Morinaga N., Yahiro K., Noda M. Resveratrol, a natural polyphenolic compound, inhibits cholera toxin-induced cyclic AMP accumulation in Vero cells. Toxicon 2010, 56(1):29-35.
15. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. Clinical Microbiology Reviews 1998, 11:142-201.
16. Niewold T.A., van Dijk A.J., Geenen P.L., Roodink H., Margry R., van der Meulen J. Dietary specific antibodies in spray-dried immune plasma prevent enterotoxigenic Escherichia coli F4 (ETEC) post weaning diarrhoea in piglets. Veterinary Microbiology 2007, 124:362-369.
17. Nishikawa K., Watanabe M., Kita E., Igai K., Omata K., Yaffe M.B., et al. Amultivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin. The FASEB Journal 2006, 20(14):2597-2599.
18. Okubo S., Sasaki T., Hara Y., Mori F., Shimamura T. Bactericidal and anti-toxin activities of catechin on enterohemorrhagic Escherichia coli. Kansenshogaku Zasshi 1998, 72:211-217.
19. Quinones B., Massey S., Friedman M., Swimley M.S., Teter K. Novel cell-based method to detect Shiga toxin 2 from Escherichia coli O157:H7 and inhibitors of toxin activity. Applied and Environmental Microbiology 2009, 75:1410-1416.
20. Rasooly R., Do P.M., Levin C.E., Friedman M. Inhibition of Shiga toxin 2 (Stx2) in apple juices and its resistance to pasteurization. Journal of Food Science 2010, 75(5):M296-M301.
21. Saenz J.B., Doggett T.A., Haslam D.B. Identification and characterization of small molecules that inhibit intracellular toxin transport. Infection and Immunity 2007, 75:4552-4561.
22. Smith M.J., Melton-Celsa A.R., Sinclair J.F., Carvalho H.M., Robinson C.M., O'Brien A.D. Monoclonal antibody 11E10, which neutralizes Shiga toxin type 2 (Stx2), recognizes three regions on the Stx2 A subunit, blocks the enzymatic action of the toxin invitro, and alters the overall cellular distribution of the toxin. Infection and Immunity 2009, 77(7):2730-2740.
23. Stein P.E., Boodhoo A., Tyrrell G.J., Brunton J.L., Read R.J. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E.coli. Nature 1992, 355:748-750.
24. Sugita-Konishi Y., Hara-Kudo Y., Amano F., Okubo T. Epigallocatechin gallate and gallocatechin gallate in green tea catechins inhibit extracellular release of Vero toxin from enterohemorrhagic Escherichia coli O157:H7. Biochimica et Biophysica Acta 1999, 1472:42-50.
25. Tagashira M., Yahiro K., Morinaga N., Moss J., Noda M. Protection with hop bract polyphenol of mice infected with enterohemorrhagic Escherichia coli O157:H7 through inhibition of Shiga toxin-1 toxicity. 38th U.S.-Japan cholera and other bacterial Enteric Infections Joint Panel Meeting 2003, 45-48. U.S. Department of Health and Human Disease, Public Health Service, National Institutes of Health, Bethesda, MD.
26. Verhelst R., Schroyen M., Buys N., Niewold T.A. E.coli heat labile toxin (LT) inactivation by specific polyphenols is aggregation dependent. Veterinary Microbiology 2013, 163(3-4):319-324.